The Cannabis M&A Wave Is Here. Curaleaf Proved It. Should Green Thumb Ride It—or Wait to Be Swept Up?

Transmission logic: M&A momentum lifts sector valuations as leaders can either scale via consolidation or command takeover premiums, broadly improving sentiment.

1. #1GTBIFGreen Thumb Industries

   +5%

   🟢it lifts attention only — fundamentals unchanged, the effect lasts weeks, price has barely reacted.

   Named directly in the news; the market is pricing in either an acquirer role or a premium takeover, both bullish narratives.

   🟢 Not yet digestedSentimentUnpricedgap +5%

2. #2CURLFCuraleaf Holdings

   +4%

   🟢the impact lands on revenue, the effect lasts weeks, price has barely reacted.

   As the first mover on dealmaking, the market rewards its consolidation strategy and expected scale benefits.

   🟢 Not yet digestedRevenueUnpricedgap +4%

3. #3TCNNFTrulieve Cannabis2nd-order

   +3%

   🟢affected indirectly (second-order), it lifts attention only — fundamentals unchanged, the effect lasts weeks, price has barely reacted.

   A top-tier MSO that benefits from spillover consolidation expectations as a potential acquirer or target.

   🟢 Not yet digestedSentimentUnpricedgap +3%

4. #4CRLBFCresco Labs2nd-order

   +3%

   🟢affected indirectly (second-order), it lifts attention only — fundamentals unchanged, the effect lasts weeks, price has barely reacted.

   The deal wave lifts peer valuations, with smaller players more likely to become premium takeover targets.

   🟢 Not yet digestedSentimentUnpricedgap +3%

5. #5VRNOFVerano Holdings2nd-order

   +2.5%

   💬affected indirectly (second-order), it lifts attention only — fundamentals unchanged, the effect lasts weeks.

   A mid-cap MSO seeing rising takeover-premium expectations under the consolidation narrative.

   Sentiment